Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000917:Antibody Formation; D000941:Antigens; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology*; D001345:Autoradiography; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002699:Chlorambucil / Q000627:therapeutic use; D004731:Endotoxins / Q000494:pharmacology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D037102:Lectins; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D012882:Skin Tests; D013057:Spectrum Analysis; D013300:Streptokinase / Q000494:pharmacology; D013745:Tetanus Toxoid; D005719:gamma-Globulins
D000941:Antigens; D000970:Antineoplastic Agents; D004731:Endotoxins; D007166:Immunosuppressive Agents; D037102:Lectins; D013745:Tetanus Toxoid; D005719:gamma-Globulins; D002699:Chlorambucil; D013300:Streptokinase; D001379:Azathioprine